Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Center_for_Biologics_Evaluation_and_Research> ?p ?o. }
Showing items 1 to 21 of
21
with 100 items per page.
- Center_for_Biologics_Evaluation_and_Research abstract "The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Dr. Karen Midthun, M.D. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biologics and related products (such as vaccines, live biotherapeutics (probiotics), blood products, and cell, tissue, and gene therapies). Not all biologics are regulated by CBER. Monoclonal antibodies and other therapeutic proteins are regulated by the FDA Center for Drug Evaluation and Research (CDER).".
- Center_for_Biologics_Evaluation_and_Research wikiPageExternalLink default.htm.
- Center_for_Biologics_Evaluation_and_Research wikiPageExternalLink CBER.
- Center_for_Biologics_Evaluation_and_Research wikiPageID "4627439".
- Center_for_Biologics_Evaluation_and_Research wikiPageRevisionID "603763478".
- Center_for_Biologics_Evaluation_and_Research hasPhotoCollection Center_for_Biologics_Evaluation_and_Research.
- Center_for_Biologics_Evaluation_and_Research subject Category:1902_establishments_in_the_United_States.
- Center_for_Biologics_Evaluation_and_Research subject Category:Blood_banks.
- Center_for_Biologics_Evaluation_and_Research subject Category:Food_and_Drug_Administration.
- Center_for_Biologics_Evaluation_and_Research subject Category:Influenza.
- Center_for_Biologics_Evaluation_and_Research subject Category:Medical_research_institutes_in_the_United_States.
- Center_for_Biologics_Evaluation_and_Research subject Category:National_Influenza_Centres.
- Center_for_Biologics_Evaluation_and_Research subject Category:Regulators_of_biotechnology_products.
- Center_for_Biologics_Evaluation_and_Research subject Category:Vaccination-related_organizations.
- Center_for_Biologics_Evaluation_and_Research comment "The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Dr. Karen Midthun, M.D. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biologics and related products (such as vaccines, live biotherapeutics (probiotics), blood products, and cell, tissue, and gene therapies).".
- Center_for_Biologics_Evaluation_and_Research label "Center for Biologics Evaluation and Research".
- Center_for_Biologics_Evaluation_and_Research sameAs m.0cdcxw.
- Center_for_Biologics_Evaluation_and_Research sameAs Q5059524.
- Center_for_Biologics_Evaluation_and_Research sameAs Q5059524.
- Center_for_Biologics_Evaluation_and_Research wasDerivedFrom Center_for_Biologics_Evaluation_and_Research?oldid=603763478.
- Center_for_Biologics_Evaluation_and_Research isPrimaryTopicOf Center_for_Biologics_Evaluation_and_Research.